XML 48 R38.htm IDEA: XBRL DOCUMENT v3.25.1
Collaborations and Other Arrangements - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Revenue $ 12,728.5 $ 8,768.0
Jardiance    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Revenue 1,014.4 $ 686.5
Jardiance | One Time Payment    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Revenue 370.0  
Boehringer Ingelheim | Milestone Payments, Sales-based    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Potential achievements 610.0  
Ebglyss | Milestone Payments, Sales-based    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Potential achievements 1,250.0  
Ebglyss | Milestone Payments, Sales-based | Roche    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Potential achievements 1,030.0  
Orforglipron | Milestone Payments, Sales-based | Chugai    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Potential achievements 250.0  
Orforglipron | Milestone Payments, Development and Regulatory | Chugai    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Potential achievements $ 140.0